Outcome of small-bowel motor impairment in systemic sclerosis - A prospective manometric 5-yr follow-up

Rheumatology

Volumn 46, Issue 1, 2007, Pages 150-153

  Marie, Isabelle ^a   Ducrotte P ^a   Denis, P ^a   Hellot, M F ^a   Levesque, H ^a  

^a ROUEN UNIVERSITY HOSPITAL   (France)

Author keywords

Digestive Raynaud's phenomenon; Small bowel involvement; Small bowel manometry; Small bowel motor impairment course; Systemic sclerosis

Indexed keywords

BOSENTAN; CISAPRIDE; DILTIAZEM; DOMPERIDONE; OCTREOTIDE; PENICILLAMINE; PREDNISOLONE; PROTON PUMP INHIBITOR;

ABDOMINAL PAIN; ADULT; AGED; ARTICLE; BLOATING; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DETERIORATION; DIARRHEA; DIET RESTRICTION; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; INTESTINAL DYSMOTILITY; INTESTINE MOTILITY; MANOMETRY; MEDICAL ASSESSMENT; MEDICAL DECISION MAKING; MIGRATING MYOELECTRIC COMPLEX; MOTOR DYSFUNCTION; NAUSEA AND VOMITING; OUTCOME ASSESSMENT; POSTPRANDIAL STATE; PRIORITY JOURNAL; SMALL INTESTINE; SYMPTOM; SYSTEMIC SCLEROSIS;

ADULT; AGED; DISEASE PROGRESSION; FASTING; FEMALE; FOLLOW-UP STUDIES; GASTROINTESTINAL AGENTS; GASTROINTESTINAL MOTILITY; HUMANS; INTESTINAL DISEASES; INTESTINE, SMALL; MANOMETRY; MIDDLE AGED; OCTREOTIDE; POSTPRANDIAL PERIOD; PROGNOSIS; PROSPECTIVE STUDIES; SCLERODERMA, SYSTEMIC;

EID: 33845564300     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kel203     Document Type: Article

References (29)

1. Jiranek GC, Bredfelt JE. Organ involvement: Gut and hepatic manifestations. In: Clements PJ, Furst DE, eds. Systemic sclerosis. Baltimore: Williams & Wilkins, 1996;453-82.
2. Marie I, Dominique S, Levesque H et al. Esophageal involvement and pulmonary manifestations in systemic sclerosis. Arthritis Rheum 2001;45:346-54.
3. Marie I, Levesque H, Ducrotté P et al. Manometry of the upper intestinal tract in patients with systemic sclerosis: A prospective study. Arthritis Rheum 1998;41:1874-83.
4. Marie I, Levesque H, Ducrotté P et al. Gastric involvement in systemic sclerosis: A prospective study. Am J Gastroenterol 2001;96:77-83.
5. Sjögren RW. Gastrointestinal motility disorders in scleroderma. Arthritis Rheum 1994;37:1265-82.
6. Sjögren RW. Gastrointestinal features of scleroderma. Curr Opin Rheumatol 1996;8:569-75.
7. Abu-Shakra M, Guillemin F, Lee P. Gastrointestinal manifestations of systemic sclerosis. Semin Arthritis Rheum 1994;24:29-39.
8. Cohen S, Laufer I, Snape WJ, Shiau YF, Levine GM, Jimenez S. The gastrointestinal manifestations of scleroderma: Pathogenesis and management. Gastroenterology 1980;79:155-66.
9. Greydanus MP, Camilleri M. Abnormal postcibal antral and small-bowel motility due to neuropathy or myopathy in systemic sclerosis. Gastroenterology 1989;96:110-5.
10. Rees WDW, Leigh RJ, Christofides ND, Bloom SR, Turnberg LA. Interdigestive motor activity in patients with systemic sclerosis. Gastroenterology 1982;83:575-80.
11. Weston S, Thumshirn M, Wiste J, Camilleri M. Clinical and upper gastrointestinal motility features in systemic sclerosis and related disorders. Am J Gastroenterol 1998;93:1085-9.
12. Marie I, Levesque H, Ducrotté P, Courtois H. Atteinte de l'intestin grêle au cours de la sclérodermie systémique. Rev Méd Interne 1999;20:504-13.
13. Poirier TJ, Rankin GB. Gastrointestinal manifestations of progressive systemic scleroderma based on a review of 364 cases. Am J Gastroenterol 1972;58:30-44.
14. Hesselstrand R, Scheja A, Akesson A. Mortality and causes of death in a Swedish series of systemic sclerosis patients. Ann Rheum Dis 1998;57:682-6.
15. Mayes MD, Lacey JV Jr, Beebe-Dimmer J et al. Prevalence, incidence, survival and disease characteristics of systemic sclerosis in a large US population. Arthritis Rheum 2003;48:2246-55.
16. Medsger TA Jr, Masi AT, Rodnan GP, Benedek TJ, Robinson H. Survival with systemic sclerosis (scleroderma): A life-table analysis of clinical and demographic factors in 309 patients. Ann Intern Med 1971;75:369-76.
17. Scussel-Lonzetti L, Joyal F, Raynauld JP et al. Predicting mortality in systemic sclerosis. Analysis of a cohort of 309 French Canadian patients with emphasis of features at diagnosis as predictive factors for survival. Medicine 2002;81:154-67.
18. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980;23:581-90.
19. Clements P, Lachenbruch P, Siebold J et al. Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis. J Rheumatol 1995;22:1281-5.
20. Vantrappen G, Janssens J, Peeters TL, Bloom SR, Christofides N, Blom S. Studies on the interdigestive (migrating) motor complex in man. In: H Duthie, ed. Gastrointestinal motility in health and disease. Lancaster (UK): MTP Press, 1978;3-8.
21. Riachi G, Ducrotte P, Guedon C et al. Duodenojejunal motility after oral and enteral nutrition in humans: A comparative study. J Parenter Enteral Nutr 1996;20:250-5.
22. Kellow JE, Borody TJ, Phillips SF, Tucker RL, Haddad AC. Human interdigetsive motility: Variations in patterns from esophagus to colon. Gastroenterology 1986;91:386-95.
23. LeRoy EC, Black C, Fleischmajer R et al. Scleroderma (systemic sclerosis): Classification, subsets and pathogenesis. J Rheumatol 1988;15:202-5.
24. Camilleri M. Study of human gastroduodenal motility: Applied physiology in clinical practice. Dig Dis Sci 1993;38:250-5.
25. Soffer EE, Thongsawat S, Ellerbroek S. Prolonged ambulatory duodeno-jejunal manometry in humans: Normal values and gender effect. Am J Gastroenterol 1998;93:1318-23.
26. Horowitz M, Maddern GJ, Maddox A, Wishart J, Chatterton BE, Shearman DJ. Effects of cisapride on gastric and esophageal emptying in progressive systemic sclerosis. Gastroenterology 1987;93:311-5.
27. Malcolm A, Ellard K. Intestinal perforation associated with octreotide therapy in scleroderma. Am J Gastroenterol 2001;96:3206-8.
28. D'Angelo WA, Fries JF, Masi AT, Schulman LE. Pathologic observations in systemic sclerosis (scleroderma): A study of fifty-eight autopsy cases and fifty-eight matched controls. Am J Med 1969;46:428-40.
29. Hansen MB. Small intestinal manometry. Physiol Res 2002;51:541-56.